Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+8.56%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$82.3B
AUM Growth
+$3.23B
(+4.1%)
Cap. Flow
-$8.69B
Cap. Flow
% of AUM
-10.56%
Top 10 Holdings %
Top 10 Hldgs %
24.03%
Holding
2,529
New
201
Increased
563
Reduced
953
Closed
424
Top Buys
| 1 |
Apple
AAPL
|
+$927M |
| 2 |
Exelon
EXC
|
+$625M |
| 3 |
Broadcom
AVGO
|
+$519M |
| 4 |
CRH
CRH
|
+$437M |
| 5 |
Marvell Technology
MRVL
|
+$283M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$839M |
| 2 |
Norfolk Southern
NSC
|
+$575M |
| 3 |
PPL Corp
PPL
|
+$355M |
| 4 |
Union Pacific
UNP
|
+$328M |
| 5 |
Cisco
CSCO
|
+$284M |
Sector Composition
| 1 | Technology | 23.46% |
| 2 | Financials | 14.23% |
| 3 | Healthcare | 13.09% |
| 4 | Industrials | 10.07% |
| 5 | Consumer Discretionary | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCBC
1551
DELISTED
Macatawa Bank Corp
MCBC
| $50K | ﹤0.01% |
5,166
-433
| -8% | -$4.19K |
|
1552
Elbit Systems
ESLT
$23.4B
| $49K | ﹤0.01% |
237
-18
| -7% | -$3.72K |
|
1553
Knife River
KNF
$4.59B
| $49K | ﹤0.01% |
610
-2,104
| -78% | -$169K |
|
1554
Precigen
PGEN
$1.23B
| $49K | ﹤0.01% |
34,478
-5,879
| -15% | -$8.36K |
|
1555
Stoke Therapeutics
STOK
$1.27B
| $49K | ﹤0.01% |
3,710
-2,069
| -36% | -$27.3K |
|
1556
Teleflex
TFX
$5.82B
| $49K | ﹤0.01% |
219
-19
| -8% | -$4.25K |
|
|
NAPA
1557
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $49K | ﹤0.01% |
5,294
| – | – |
|
1558
ABM Industries
ABM
$2.86B
| $48K | ﹤0.01% |
1,079
+1,030
| +2,102% | +$45.8K |
|
1559
4D Molecular Therapeutics
FDMT
$327M
| $48K | ﹤0.01% |
1,533
-7,981
| -84% | -$250K |
|
1560
Fresh Del Monte Produce
FDP
$1.7B
| $48K | ﹤0.01% |
+1,871
| New | +$48K |
|
1561
Foster
FSTR
$289M
| $48K | ﹤0.01% |
1,789
+1,581
| +760% | +$42.4K |
|
1562
Sight Sciences
SGHT
$189M
| $48K | ﹤0.01% |
9,128
-654
| -7% | -$3.44K |
|
1563
Turning Point Brands
TPB
$1.8B
| $48K | ﹤0.01% |
+1,663
| New | +$48K |
|
|
AXNX
1564
DELISTED
Axonics, Inc. Common Stock
AXNX
| $48K | ﹤0.01% |
699
-48
| -6% | -$3.3K |
|
1565
Nkarta
NKTX
$145M
| $47K | ﹤0.01% |
4,385
-2,225
| -34% | -$23.8K |
|
1566
Boston Beer
SAM
$2.4B
| $47K | ﹤0.01% |
155
| – | – |
|
1567
Sana Biotechnology
SANA
$792M
| $47K | ﹤0.01% |
4,814
-2,663
| -36% | -$26K |
|
|
AUTL
1568
Autolus Therapeutics
AUTL
$373M
| $46K | ﹤0.01% |
7,372
-4,179
| -36% | -$26.1K |
|
1569
Neuropace
NPCE
$329M
| $46K | ﹤0.01% |
3,541
-388
| -10% | -$5.04K |
|
1570
Regal Rexnord
RRX
$9.64B
| $46K | ﹤0.01% |
256
-11
| -4% | -$1.98K |
|
1571
Sotera Health
SHC
$4.53B
| $46K | ﹤0.01% |
3,852
-2,784
| -42% | -$33.2K |
|
|
SOR
1572
Source Capital
SOR
$373M
| $46K | ﹤0.01% |
1,087
| – | – |
|
1573
Forestar Group
FOR
$1.43B
| $45K | ﹤0.01% |
1,128
-86
| -7% | -$3.43K |
|
1574
Kirby Corp
KEX
$4.94B
| $45K | ﹤0.01% |
+476
| New | +$45K |
|
1575
Sylvamo
SLVM
$1.76B
| $45K | ﹤0.01% |
+730
| New | +$45K |
|